Skip to main content
VCbacked
Log inGet Started

Microplate Dx

Glasgow, United Kingdom

Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.

$645K raised
Sep 2025
Venture - Series Unknown
BiotechnologyHealth CareMedical

Top Investors

University of StrathclydeScottish EnterpriseDeepbridge CapitalSIS VenturesThairm Bio

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Microplate Dx

How much funding has Microplate Dx raised?
Microplate Dx has raised $645K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Who are Microplate Dx's investors?
Microplate Dx's investors include University of Strathclyde, Scottish Enterprise, Deepbridge Capital, SIS Ventures, Thairm Bio.
Where is Microplate Dx headquartered?
Microplate Dx is headquartered in Glasgow, United Kingdom.
What does Microplate Dx do?
Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.
What stage is Microplate Dx at?
Microplate Dx is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Microplate Dx — Funding & Investors." VCBacked, September 8, 2025, https://www.vcbacked.co/company/microplate-dx. Accessed July 2, 2026.
APA
VCBacked. (2025). Microplate Dx — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/microplate-dx
Wikipedia (cite web)
{{cite web |title=Microplate Dx — Funding & Investors |url=https://www.vcbacked.co/company/microplate-dx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K